Medicare Part D coverage · deferasirox · RxCUI 597768
deferasirox 125 MG Tablet for Oral Suspension
Per the CMS 2026 Part D formulary file, deferasirox 125 MG Tablet for Oral Suspension is covered by 3,608 Medicare Part D plans (71.4% of enrollable products), averaging Tier 3.1, with prior authorization required on 91% of covering formularies.
- 71.4%
- Plan coverage
- 3,608
- Plans covering
- T3.1
- Avg tier
- 91%
- Prior auth required
What the CMS Formulary Data Shows for deferasirox 125 MG Tablet for Oral Suspension
Per the CMS 2026 Part D formulary file, deferasirox 125 MG Tablet for Oral Suspension (RxNorm concept RXCUI 597768, generic name deferasirox) appears on 221 distinct formulary files spanning 3,608 Medicare Part D plan offerings - 71.4% of enrollable Part D products, mid-range placement; shopping across contracts changes access. Tier placement ranges from Tier 1 to Tier 5, with a cross-plan average of Tier 3.1.
Real-world access to deferasirox 125 MG Tablet for Oral Suspension depends on utilization management as much as tier placement: 91% of covering formularies require prior authorization. 0% require step therapy. 0.9% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 3,436 Part D beneficiaries filled deferasirox 125 MG Tablet for Oral Suspension in 2023, with total plan-and-beneficiary spending of $49,214,658 and an average per-beneficiary annual cost of $14,323.24. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry deferasirox 125 MG Tablet for Oral Suspension today.
Coverage Details
- Formularies covering
- 221
- Plans covering
- 3,608
- Coverage rate
- 71.4%
- Tier range
- Tier 1 – Tier 5
- Average tier
- Tier 3, Preferred Brand
Restrictions
- Prior authorization required
- 91% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 0.9% of formularies
2023 Medicare Spending
- Beneficiaries
- 3,436
- Total spending
- $49,214,658
- Avg per beneficiary
- $14,323.24
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering deferasirox 125 MG Tablet for Oral Suspension
100 Medicare Advantage plans with Part D drug coverage include this drug.
| Plan | Insurer | Tier | PA | Premium | States |
|---|---|---|---|---|---|
| Sentara Community Complete Select (HMO D-SNP) | Sentara Health Plans | T1 | Yes | $0 | VA |
| Sentara Community Complete (HMO D-SNP) | Sentara Health Plans | T1 | Yes | $0 | VA |
| Florida Complete Care-Duals VIP (HMO-POS D-SNP) | Hpmp OF Florida, Inc. | T1 | Yes | $0 | FL |
| ElderServe MAP (HMO D-SNP) | Elderserve Health, Inc. | T1 | Yes | $0 | NY |
| Cooperative Advantage (HMO D-SNP) | Group Health Cooperative OF EAU Claire | T1 | Yes | $0 | WI |
| Longevity Health Plan (PPO I-SNP) | Longevity Health Plan OF NEW Jersey Insurance Comp | T1 | Yes | $0 | NJ |
| Mercy Care Advantage (HMO D-SNP) | Mercy Care | T1 | Yes | $0 | AZ |
| Mercy Care Advantage (HMO D-SNP) | Mercy Care | T1 | Yes | $0 | AZ |
| Mercy Care Advantage (HMO D-SNP) | Mercy Care | T1 | Yes | $0 | AZ |
| Elderplan Plus Long-Term Care (HMO-POS D-SNP) | Elderplan, Inc. | T1 | Yes | $0 | NY |
| Health Choice Pathway (HMO D-SNP) | Health Choice Arizona, Inc. | T1 | Yes | $0 | AZ |
| Healthfirst CompleteCare (HMO D-SNP) | Healthfirst Health Plan, Inc. | T1 | Yes | $0 | NY |
| IMCare Classic (HMO D-SNP) | Itasca Medical Care | T1 | Yes | $0 | MN |
| Johns Hopkins Advantage MD D-SNP (HMO D-SNP) | Hopkins Health Advantage, Inc. | T1 | Yes | $0 | MD |
| MetroPlus UltraCare (HMO D-SNP) | Metroplus Health Plan, Inc. | T1 | Yes | $0 | NY |
| Upper Peninsula Health Plan MI Coordinated Health (HMO D-SNP) | Upper Peninsula Health Plan, LLC | T1 | Yes | $0 | MI |
| CareSource Dual Advantage (HMO D-SNP) | Caresource Georgia Co. | T1 | Yes | $0 | GA |
| Senior Whole Health SCO (HMO D-SNP) | Senior Whole Health, LLC | T1 | Yes | $0 | MA |
| Senior Whole Health SCO NHC (HMO D-SNP) | Senior Whole Health, LLC | T1 | Yes | $0 | MA |
| Molina One Care (HMO D-SNP) | Senior Whole Health, LLC | T1 | Yes | $0 | MA |
Show the next 30 plans
| HAP CareSource MI Coordinated Health (HMO D-SNP) | HAP Caresource | T1 | Yes | $0 | MI |
| CareAdvantage (HMO D-SNP) | SAN Mateo Health Commission | T1 | Yes | $0 | CA |
| Gold Coast Health Plan Total Care Advantage (HMO D-SNP) | Ventura County Medi-Cal Managed Care Commission | T1 | Yes | $0 | CA |
| Blue Cross Medicare Advantage Dual Care Plus (HMO D-SNP) | Health Care Service Corporation | T1 | Yes | $0 | NM |
| Blue Cross MA Dual Care Plus Preferred (PPO D-SNP) | Health Care Service Corporation | T1 | Yes | $0 | NM |
| Horizon NJ TotalCare (HMO D-SNP) | Horizon Healthcare OF NEW Jersey, Inc. | T1 | Yes | $0 | NJ |
| SecureBlue (HMO D-SNP) | HMO Minnesota | T1 | Yes | $0 | MN |
| NaviCare (HMO D-SNP) | Fallon Community Health Plan | T1 | No | $0 | MA |
| Hamaspik Medicare Choice (HMO D-SNP) | Hamaspik, Inc. | T1 | Yes | $0 | NY |
| SeniorCare Complete (HMO D-SNP) | South Country Health Alliance | T1 | Yes | $0 | MN |
| AbilityCare (HMO D-SNP) | South Country Health Alliance | T1 | Yes | $0 | MN |
| Alameda Alliance Wellness (HMO D-SNP) | Alameda Alliance FOR Health | T1 | Yes | $0 | CA |
| PHP (HMO C-snp) | Aids Healthcare Foundation | T1 | Yes | $0 | CA |
| CCA One Care (HMO D-SNP) | Commonwealth Care Alliance, Inc. | T1 | Yes | $0 | MA |
| CCA Senior Care Options (HMO D-SNP) | Commonwealth Care Alliance, Inc. | T1 | Yes | $0 | MA |
| VNS Health Total (HMO D-SNP) | VNS Choice | T1 | Yes | $0 | NY |
| Provider Partners Pennsylvania Community Plan (HMO I-SNP) | Provider Partners Health Plan OF Pennsylvania, Inc | T1 | Yes | $0 | PA |
| Provider Partners North Carolina Community Plan (HMO I-SNP) | Provider Partners Health Plan OF North Carolina | T1 | Yes | $0 | NC |
| Provider Partners Indiana Community Plan (HMO I-SNP) | Provider Partners Health Plan OF Indiana | T1 | Yes | $0 | IN |
| Provider Partners Missouri Community Plan (HMO I-SNP) | Provider Partners Health Plan OF Missouri, Inc. | T1 | Yes | $0 | MO |
| Community Care's Partnership Program (HMO D-SNP) | Community Care Health Plan, Inc. | T1 | No | $0 | WI |
| CalOptima Health OneCare Complete (HMO D-SNP) | Orange County Health Authority | T1 | Yes | $0 | CA |
| Mass General Brigham SCO (HMO D-SNP) | Mass General Brigham Health Plan, Inc | T1 | Yes | $0 | MA |
| Mass General Brigham One Care (HMO D-SNP) | Mass General Brigham Health Plan, Inc | T1 | Yes | $0 | MA |
| Highmark Wholecare Medicare Assured Diamond (HMO D-SNP) | Gateway Health Plan, Inc. | T1 | Yes | $0 | PA |
| Highmark Wholecare Medicare Assured Diamond (HMO D-SNP) | Gateway Health Plan, Inc. | T1 | Yes | $0 | PA |
| Highmark Health Options Duals (HMO D-SNP) | Highmark Health Options West Virginia Inc. | T1 | Yes | $0 | WV |
| Highmark Health Options Duals (HMO D-SNP) | Highmark Bcbsd, Inc. | T1 | Yes | $0 | DE |
| Tufts Health One Care (HMO D-SNP) | Tufts Health Public Plans, Inc. | T1 | No | $0 | MA |
| Tufts Health One Care CW (HMO D-SNP) | Tufts Health Public Plans, Inc. | T1 | No | $0 | MA |
Showing top 50 of 100 plans.
Frequently Asked Questions
Is deferasirox 125 MG Tablet for Oral Suspension covered by Medicare Part D?
Yes, deferasirox 125 MG Tablet for Oral Suspension is covered by 3,608 Medicare Part D plans (71.4% of all Part D formularies).
What tier is deferasirox 125 MG Tablet for Oral Suspension on Medicare Part D plans?
deferasirox 125 MG Tablet for Oral Suspension averages Tier 3.1 across Part D plans, ranging from Tier 1 to Tier 5.
Does deferasirox 125 MG Tablet for Oral Suspension require prior authorization?
91% of Part D formularies require prior authorization for deferasirox 125 MG Tablet for Oral Suspension. Step therapy: 0%. Quantity limits: 0.9%.
How much does Medicare spend on deferasirox 125 MG Tablet for Oral Suspension?
In 2023, total Medicare Part D spending on deferasirox 125 MG Tablet for Oral Suspension was $49,214,658, covering 3,436 beneficiaries. The average spend per beneficiary was $14,323.24.
Read our methodology - how this data is sourced, computed, and verified.
Nationwide similar Part D drugs
Data-derived peers across the CMS Part D formulary extract: nearest average tier placement and nearest prior-authorization rate. Not therapeutic alternatives or same-generic strengths.
Closest average formulary tier
- tigecycline 50 MG Injection T3.1
- isotretinoin 10 MG Oral Capsule [Amnesteem] T3.1
- azelaic acid 0.15 MG/MG Topical Gel T3.1
- insulin, regular, human 500 UNT/ML Injectable Solution [Humulin R] T3.1
- nalmefene 27 MG/ML Nasal Spray [Opvee] T3.1
- {14 (lamotrigine 100 MG Oral Tablet) / 84 (lamotrigine 25 MG Oral Tablet) } Pack T3.1
Similar prior-authorization rate
- tretinoin 0.0001 MG/MG Topical Gel 91% PA
- tretinoin 0.00025 MG/MG Topical Gel 91% PA
- 1 ML rabies virus vaccine flury-lep strain 2.5 UNT/ML Injection [RabAvert] 90.9% PA
- posaconazole 100 MG Delayed Release Oral Tablet 90.9% PA
- leuprolide acetate 22.5 MG Injection 91.2% PA
- 0.2 ML adalimumab-adbm 50 MG/ML Prefilled Syringe 90.7% PA